Pfizer Profit Up on Demand for Key Drugs
84586
Pfizer Inc. PFE.N, the world's  biggest drugmaker, on Wednesday said third-quarter earnings  rose on higher sales of key medicines.
275333
Medco Health Solutions Inc. , one of the largest U.S. managers of drug benefits, said on Wednesday that profit rose 29 percent, as higher rates of mail-delivered generic drugs drove better profit margins, and it lifted its full-year earnings forecast.
644301
Diversified health-care company Johnson &amp; Johnson on Tuesday said its quarterly profit rose on higher sales of prescription drugs and medical devices.
356134
Merck & Co  on Monday said its  third-quarter profit rose sharply, helped by sales of its  vaccines and cholesterol drugs, and raised its 2007 profit  forecast in view of strong current trends.
12838
Pfizer Inc. shares staged a rebound Tuesday, spurred in part by what Wall Street viewed as positive publicity about its Celebrex drug.
668144
Johnson &amp; Johnson, which makes products ranging from heart stents to Band-Aids, said third- quarter profit rose 13 percent on higher sales of drugs used to treat rheumatoid arthritis and schizophrenia.
732908
The company said fourth-quarter earnings rose 17 percent on higher sales of its Enbrel arthritis drug and Prevnar vaccine, but said generic competition would hit 2008 profit.
549877
The drug maker Schering-Plough Corporation said yesterday that its fourth-quarter profit surged 75 percent as strong sales of its cholesterol, arthritis and allergy medicines helped offset rising research and marketing spending.
510118
Sanofi-Aventis  posted higher-than-expected fourth-quarter current operating profit, despite healthcare savings in Europe as well as generic rivalry, and the drugmaker predicted more growth for 2007.
382374
The Swiss pharmaceutical giant, Novartis, on Tuesday announced an 18 percent increase in second quarter net profit to 2.02 billion dollars (1.46 billion euros) and reiterated its forecast of record profits this year.
302848
U.S. stocks rose on Monday as a slew of acquisition deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc. , which dropped a key experimental drug.
535789
Net profit at Roche Holding  AG  rose 34 percent to 9.17 billion Swiss francs ($7.33  billion) in 2006 due to strong sales of cancer treatments  Herceptin and Avastin, just ahead of analysts' expectations.
568776
Walgreen Co , one of the largest U.S. drugstore operators, said on Friday quarterly profit rose a better-than-expected 5.5 percent, helped by higher sales and cost controls.
478489
Johnson & Johnson posted a 9 percent increase in second-quarter profit yesterday, as the acquisition of Pfizerâs consumer health products line offset a continuing decline in sales of its stents and a top drug.
555469
Diversified health-care company  Johnson & Johnson JNJ.N on Tuesday said its quarterly profit  rose on higher sales of prescription drugs and medical devices.
212952
Pfizer Inc.  on Thursday said  second-quarter earnings from continuing operations rose about  13 percent on higher sales of medicines like cholesterol  fighter Lipitor and Celebrex for arthritis.
224792
Abbott Laboratories, the maker of health-care products ranging from pediatric nutritional drinks to HIV tests, said third-quarter profit rose 15 percent as prescriptions climbed for its Humira rheumatoid-arthritis drug.